company has submitted book closure on 09.09.2024 was related to AGM purpose only, for dividend purpose company has fix a separate record date i.e. 30.09.2024

pdf

ADS Diagnostic Ltd.

09 Sep 2024

Corp. Action

ADS DIAGNOSTIC LTD. - 523031 - Intimation Of Book Closure Pursuant To Regulation 42 Of The …

BSE India

register of members and share transfer books of the company will remain closed from 22.09.2024 to 28.09.2024 for taking the records of the members for convening the 39th annual general meeting of ads diagnostic limited, the AGM of company is scheduled on 28.09.2024

pdf

ADS Diagnostic Ltd.

31 Aug 2024

Corp. Note

ADS DIAGNOSTIC LTD. - 523031 - Reg. 34 (1) Annual Report.

BSE India

NOTICE IS HEREBY GIVEN that the 39th Annual General Meeting of the Members of ADS Diagnostic Limited will be held on Saturday, the 28th September, 2024, at 11:30 A.M. Through Video Conferencing ('VC')/ other Audio Visual means ('OAVM') facility

pdf

ADS Diagnostic Ltd.

13 Aug 2024

Board Meeting

ADS DIAGNOSTIC LTD. - 523031 - Board Meeting Outcome for Outcome Of The Board Meeting For …

BSE India

we wish to inform you that the Board of Directors (the ''Board'') of ADS Diagnostic Limited (''the Company'') at its meeting held today i.e. Tuesday, August 13th, 2024 considered and approved the Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2024

pdf

ADS Diagnostic Ltd.

02 Aug 2024

Board Meeting

ADS DIAGNOSTIC LTD. - 523031 - Board Meeting Intimation for Notice Of Board Meeting Under Regulation …

BSE India

ADS DIAGNOSTIC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 13th August, 2024 at the Registered Office of the Company, to inter alia transact the following business. 1. To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June, 2024. 2. To consider and transit any other businesses, if any, which may be placed before the Board with the permission of the Chairman.

pdf